Related references
Note: Only part of the references are listed.Is It Safe to Use Long-Acting G-CSF for Febrile Neutropenia Prophylaxis in COVID-19 Pandemic?
Yakupo Ergun et al.
JCO ONCOLOGY PRACTICE (2021)
Is It Safe to Use Long-Acting G-CSF for Febrile Neutropenia Prophylaxis in COVID-19 Pandemic? Reply
Angioletta Lasagna et al.
JCO ONCOLOGY PRACTICE (2021)
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers A Randomized Clinical Trial
Benjamin S. Abella et al.
JAMA INTERNAL MEDICINE (2021)
Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System
Taurean Brown et al.
BIOMEDICINES (2021)
Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence
Elissar Moujaess et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
G-CSF attenuates neuroinflammation and neuronal apoptosis via the mTOR/p70SK6 signaling pathway in neonatal Hypoxia-Ischemia rat model
John Sieh Dumbuya et al.
BRAIN RESEARCH (2020)
Neurogenic Heterotopic Ossifications Develop Independently of Granulocyte Colony-Stimulating Factor and Neutrophils
Hsu-Wen Tseng et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
The role of Hippo signal pathway in breast cancer metastasis
Changran Wei et al.
ONCOTARGETS AND THERAPY (2018)
Comparison of the effects of pegylated granulocyte-colony stimulating factor and granulocyte-colony stimulating factor on cytopenia induced by dose-dense chemotherapy in breast cancer patients
Farzaneh Ashrafi et al.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2018)
Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic Review
John Lally et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC)
Caicun Zhou et al.
CLINICAL LUNG CANCER (2016)
Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review
Sarah Mitchell et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2016)
Clinical observation of the therapeutic effects of pegylated recombinant human granulocyte colony-stimulating factor in patients with concurrent chemoradiotherapy-induced grade IV neutropenia
Feng-Peng Wu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?
Andreas Baumann et al.
DRUG DISCOVERY TODAY (2014)
New G-CSF agonists for neutropenia therapy
Jonathan Hoggatt et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Pegfilgrastim ± ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer.: Results from the GEPARTRIO study
G. von Minckwitz et al.
ANNALS OF ONCOLOGY (2008)
Share Paper
